The box office story is real and worth stating plainly: $15 million on 855 screens is the best opening weekend for a documentary since Michael Moore's Fahrenheit 9/11 in 2004, and the best limited opening for any film since Borat in 2006. Two thousand sold-out screenings. A 97 on Metacritic. Near-perfect Rotten Tomatoes. Highest-rated film on Letterboxd. These are not the numbers of a prestige niche. They are the numbers of a cultural event. What's driving the surge matters as much as the surge itself. The Dropout — Hulu's 2022 dramatization starring Amanda Seyfried — jumped 186% in viewership after You Can See Everything's teaser dropped on September 6, then nearly doubled again the week before the film's October 16 premiere. Bad Blood, John Carreyrou's 2018 account of the Theranos collapse, returned to the New York Times bestseller list. This is a documentary functioning as a franchise ignition event — pulling audiences backward through the archive rather than simply harvesting existing interest. The production context is load-bearing. Fielder and Oppenheim filmed largely in secret in 2023, in the month before Holmes began serving her 11-year federal sentence for fraud. A24 produced. The film runs three hours. It went into theaters with almost no conventional marketing infrastructure — word of mouth and spoiler discipline did the work. The fact that critics and audiences are being deliberately vague about the second half suggests the film earns its third act in a way that changes what you think you've been watching. The Oscar campaign is unusual enough to be worth noting. A24 is submitting You Can See Everything not just in documentary categories but in cinematography, score, director, costume design, production design, and makeup and hairstyling. The first documentary ever nominated for best picture would be a genuine category first. Amanda Seyfried — who starred in the Hulu dramatization, not this film — is being campaigned for best supporting actress, which signals something specific about the film's structure that reviewers are declining to explain. The Holmes story has proven unusually durable as cultural material — the subject of a book, a podcast, a dramatization, now a documentary generating the kind of numbers usually reserved for superhero IP. The question the box office doesn't answer is whether You Can See Everything is a great film that happens to have a great subject, or a great film that transcends its subject entirely. Every available signal points toward the latter. The sold-out screenings, the spoiler embargo, the cross-category Oscar campaign, the Letterboxd numbers — these are the signatures of a film people are treating as an experience rather than an explainer.
